<DOC>
	<DOC>NCT00939185</DOC>
	<brief_summary>The objective of this study was to obtain data on the safety, tolerability and compliance with Zithromax in children with bacterial infections of the upper and lower respiratory tract.</brief_summary>
	<brief_title>Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections</brief_title>
	<detailed_description>Patients were recruited from the outpatient departments of the participating sites/hospitals/clinics.</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Patients with respiratory tract infections that received azithromycin according to the approved SPC as this was a noninterventional study. According to the approved Summary of Product Characteristics (SPC) for Azithromycin as this was a non interventional study.</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Compliance and Safety Study in Children with Upper and Lower Respiratory Tract Infections</keyword>
</DOC>